Home | Welcome to Contract Pharma   
Last Updated Wednesday, October 1 2014
Print

Breaking News

Related Searches: Vaccine Phase II Preclinical Development
February 8, 2013
To evaluate merger, sale, or other transaction  Read More »
February 8, 2013
Will share global rights to marketed products  Read More »
February 7, 2013
Revenues up 3% in the quarter, earnings hurt by generics  Read More »
February 7, 2013
Revenues down 8% in the quarter  Read More »
February 7, 2013
Revenues up 7% in the quarter  Read More »
February 7, 2013
To identify and develop antibacterial agents  Read More »
February 7, 2013
Aims to align sales force under cloud-based system  Read More »
February 7, 2013
Taylor brings nearly 30 years of experience  Read More »
February 6, 2013
Adds key locations in North America  Read More »
February 6, 2013
U.S. commercial packaging operations underway  Read More »
February 6, 2013
Revenues decline 3% in the quarter, new change program accelerates  Read More »
February 6, 2013
Will gain IB1001 and other assets from Ipsen, Inspiration  Read More »
February 6, 2013
Elan to receive $3.25 billion, royalties  Read More »
February 6, 2013
Dixon to oversee business development and promotional strategies  Read More »
February 5, 2013
Cobb to manage early-phase OSD development  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On